Home › NDC Lookup › RxCUI directory › RxCUI 2716696

2 ML spesolimab-sbzo 150 MG/ML Prefilled Syringe — RxCUI 2716696

RxNorm drug concept · Semantic clinical drug
RxCUI 2716696 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2716696
Official name2 ML spesolimab-sbzo 150 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asspesolimab-sbzo 300 MG per 2 ML Prefilled Syringe; spesolimab-sbzo 300 MG in 2 ML Prefilled Syringe
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)38 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 2 ML spesolimab-sbzo 150 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML spesolimab-sbzo 150 MG/ML Prefilled Syringe RxCUI 2716696

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Spesolimab 2610417
    • Spesolimab-sbzo 2610418
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Spevigo 2610424
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Spesolimab Prefilled Syringe 2678977
    • Spesolimab-sbzo Prefilled Syringe 2678978
    • Spesolimab Injectable Product 2610420
    • Spesolimab-sbzo Injectable Product 2660972
    • Spesolimab Prefilled Syringe [Spevigo] 2678982
    • Spesolimab-sbzo Prefilled Syringe [Spevigo] 2678983
    • Spevigo Injectable Product 2610426
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Spesolimab-sbzo 150 MG/ML SCDC · 2678976
  • Spesolimab Prefilled Syringe SCDF · 2678977
  • Spesolimab-sbzo Prefilled Syringe SCDFP · 2678978
  • Spesolimab Injectable Product SCDG · 2610420
  • Spesolimab-sbzo Injectable Product SCDGP · 2660972

Brand-Name Concepts

  • 2 ML spesolimab-sbzo 150 MG/ML Prefilled Syringe [Spevigo] SBD · 2716697
  • Spesolimab-sbzo 150 MG/ML [Spevigo] SBDC · 2678981
  • Spesolimab Prefilled Syringe [Spevigo] SBDF · 2678982
  • Spesolimab-sbzo Prefilled Syringe [Spevigo] SBDFP · 2678983
  • Spevigo Injectable Product SBDG · 2610426
  • Spevigo BN · 2610424

📦 FDA Products & Package NDCs

6 products · 8 package NDCs
8 package NDCs map to RxCUI 2716696 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0035-10 2 VIAL, GLASS in 1 CARTON (0597-0035-10) / 7.5 mL in 1 VIAL... SPEVIGO Boehringer Ingelheim Pharmaceuticals, Inc. 2022-09-01
00597-0620-20 2 SYRINGE in 1 CARTON (0597-0620-20) / 150 INJECTION in 1 S... SPEVIGO Boehringer Ingelheim Pharmaceuticals, Inc. 2024-03-18
00597-7705-41 1 SYRINGE in 1 CARTON (0597-7705-41) / 300 INJECTION in 1 S... SPEVIGO Boehringer Ingelheim Pharmaceuticals, Inc. 2025-05-28
00597-7705-72 2 SYRINGE in 1 CARTON (0597-7705-72) / 300 INJECTION in 1 S... SPEVIGO Boehringer Ingelheim Pharmaceuticals, Inc. 2025-05-28
50222-0360-72 2 VIAL, GLASS in 1 CARTON (50222-360-72) / 7.5 mL in 1 VIAL... SPEVIGO LEO Pharma Inc. 2026-03-09
50222-0361-02 2 SYRINGE, GLASS in 1 CARTON (50222-361-02) / 1 mL in 1 SYR... SPEVIGO LEO Pharma Inc. 2026-03-09
50222-0362-01 1 SYRINGE, GLASS in 1 CARTON (50222-362-01) / 2 mL in 1 SYR... SPEVIGO LEO Pharma Inc. 2026-03-09
50222-0362-02 2 SYRINGE, GLASS in 1 CARTON (50222-362-02) / 2 mL in 1 SYR... SPEVIGO LEO Pharma Inc. 2026-03-09
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (4) · LEO Pharma Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1747 Inj, spesolimab-sbzo, 1 mg 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.